Carl Byrnes
Stock Analyst at Northland Capital Markets
(3.04)
# 1,453
Out of 5,102 analysts
26
Total ratings
52.63%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BWAY BrainsWay | Maintains: Outperform | $19 → $23 | $17.42 | +32.03% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $31.50 | +74.60% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $24.88 | +24.60% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $7.50 | +66.67% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.72 | +248.84% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.83 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $14.47 | +72.77% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $3.70 | +6,386.49% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $34.10 | +134.60% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $7.16 | +221.23% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $4.08 | +488.24% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.28 | +87,619.30% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.37 | - | 1 | Sep 27, 2017 |
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $17.42
Upside: +32.03%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $31.50
Upside: +74.60%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $24.88
Upside: +24.60%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $7.50
Upside: +66.67%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.72
Upside: +248.84%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.83
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $14.47
Upside: +72.77%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $3.70
Upside: +6,386.49%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $34.10
Upside: +134.60%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $7.16
Upside: +221.23%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $4.08
Upside: +488.24%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.28
Upside: +87,619.30%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.37
Upside: -